Salivary gland tumors. Five years of experience

Authors

Keywords:

salivary gland neoplasms, pleomorphic adenoma, mucoepidermoid carcinoma

Abstract

Introduction: salivary gland neoplasms are rare. According to the literature they correspond to three and up to 6% of head and neck tumors and 0.6% of all neoplasms. They are an important variety of lesions with dissimilar biological behaviors that settle in the salivary glands.
Objective: to describe the histopathological behavior of the cases treated at the "Arnaldo Milián Castro" Hospital during five years and the treatment received for these neoplasms in the population.
Methods: a retrospective descriptive study of neoplasms of salivary origin in the Maxillofacial Surgery Service of the "Arnaldo Milián Castro" Hospital of Villa Clara between January 2014 and December 2018 was carried out. Variables such as location, histological type, degree of malignancy and therapeutic modality were studied.
Results: a total of 189 patients attended were reviewed, with a total of 189 lesions. There was a higher incidence in women (54.49%), 77.7% of the total neoplasms were located in the parotid gland, pleomorphic adenoma constituted 54.49% of all neoplasms, 75.18% of neoplasms were benign in all locations, mucoepidermoid carcinoma was the predominant malignant tumor (32.69%) and subtotal parotidectomy was the most frequently performed surgical treatment.
Conclusions: there was a predominance of benign neoplasms, the parotid was the most affected gland, with a diagnostic variety of 22 different histological variants. Subtotal parotidectomy was the most performed surgical treatment.

Downloads

Download data is not yet available.

Author Biographies

Yuniesky Jiménez Rodríguez, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I y II Grado en Cirugía Máxilo Facial. Cirujano de Cabeza y Cuello. Profesor Asistente en la Universidad de Ciencias Médicas de Villa Clara.

Rafael Michel Coca Granado, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I y II Grado en Cirugía Máxilo Facial. Cirujano de Cabeza y Cuello. Especialista en II Grado en Oncología. Profesor Auxiliar en la Universidad de Ciencias Médicas de Villa Clara.

Reynaldo Enrique Delis Fernández, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I y II Grado en Cirugía Máxilo Facial. Profesor Auxiliar en la Universidad de Ciencias Médicas de Villa Clara.

Daniel Artiles Martínez, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I Grado en Medicina General Integral. Especialista en I Grado en Anatomía Patológica. Máster en Citopatología. Profesor Asistente en la Universidad de Ciencias Médicas de Villa Clara.

Dannis Durán Morales, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Licenciada en Estomatología. Profesora Asistente en la Universidad de Ciencias Médicas de Villa Clara.

References

1.Campolo González A, Ramírez Skinner H, Vargas Díaz A, León Ramírez A, Goñi Espilpora I, Solar González A. Perfil epidemiológico de neoplasias epiteliales de glándulas salivales. Rev Med Chile [Internet]. 2018 Dic [citado 12/09/2019];146(10):[aprox. 8 p.]. Disponible en: https://scielo.conicyt.cl/pdf/rmc/v146n10/0034-9887-rmc-146-10-01159.pdf

2.Neville BW, Damm DD, Chi AC, Allen CM. Oral and Maxillofacial Pathology. 2nd ed. Philadelphia: Saunders Company; 2002.

3.Maza Solano JM, Sánchez-Gómez S, Herrero-Salado T, Benavente-Bermudo G, Ventura-Díaz J, de Mingo Fernández EJ. Clasificación pronostica de los tumores malignos de parótida. Rev Esp Cir Oral Maxilofac [Internet]. 2016 [citado 12/09/2019];38(1):[aprox. 6 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1130055815000064

4.Sotelo-Gavito JJ, Pérez-Montaño M, Alderete-Vázquez G, Capetillo-Hernández G, Grube-Pagola P. Tumores de glándulas salivales en Veracruz. Experiencia de dos instituciones. Rev Med Inst Mex Seguro Soc [Internet]. 2018 [citado 12/09/2019];56(2):[aprox. 4 p.]. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2018/im182g.pdf

5.Luksic I, Virag M, Manojlovic S, Macan D. Salivary gland tumours: 25 years of experience from a single institution in Croatia. J Craniomaxillofac Surg [Internet]. 2012 Apr [citado 12/09/2019];40(3):[aprox. 7 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21641811/. https://doi.org/10.1016/j.jcms.2011.05.002

6.Lahoz Zamarro MT, Galve Royo A, Galve Royo F. Afección tumoral de las glándulas salivales. Nuestra experiencia. Acta Otorrinolaringol Esp [Internet]. 2009 [citado 12/09/2019];60(2):[aprox. 5 p.]. Disponible en: https://www.elsevier.es/es-revista-acta-otorrinolaringologica-espanola-102-articulo-afeccion-tumoral-las-glandulas-salivales--S0001651909020081

7.Banerjee A, Saha (Ray) M. Histopathological Spectrum of Salivary Gland Tumors in Tripura, India: A Seven Year Study. IOSR-JDMS [Internet]. 2017 May [citado 29/10/2019];16(5):[aprox. 4 p.]. Disponible en: http://www.iosrjournals.org/iosr-jdms/papers/Vol16-issue5/Version-11/B1605110407.pdf. https://doi.org/10.9790/0853-1605110407

8.Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY, et al. Salivary gland tumors in a northern Chinese population: a 50 years retrospective study of 7190 cases. Int J Oral Maxillofac Surg [Internet]. 2017 [citado 29/10/2019];46:[aprox. 7 p.]. Disponible en: https://ss.bjmu.edu.cn/Sites/Uploaded/File/2018/07/106366683461021808264812766.pdf

9.Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardoun P. Salivary Gland Tumors: A 15- year Report from Iran. Turk Patoloji Derg [Internet]. 2016 [citado 29/10/2019];32:[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26832180. https://doi.org/10.5146/tjpath.2015.01336

10.Sentani K, Ogawa I, Ozasa K, Sadakane A, Utada M, Tsuya T, et al. Characteristics of 5015 Salivary Gland Neoplasms Registered in the Hiroshima Tumor Tissue Registry over a Period of 39 Years. J Clin Med [Internet]. 2019 May [citado 29/10/2019];8(5):[aprox. 10 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571736/. https://doi.org/10.3390/jcm8050566

11.Cunha Vasconcelos A, Nör F, Meurer L, Salvadori G, Batista de Souza L, Agustin Vargas P, et al. Clinicopathological analysis of salivary gland tumors over 15-year period. Braz Oral Res [Internet]. 2016 [citado 29/10/2019];30:S1806e2 [aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26676198. https://doi.org/10.1590/1807-3107bor-2016.vol30.0002

12.Braimah R, Taiwo A, Ibikunle A, Sahabi S. Clinico-Pathologic Review of Salivary Glands Neoplasms in a Nigerian University Teaching Hospital: A Five Year Retrospective Survey. Int Biol Biomed J Spring [Internet]. 2018 [citado 29/10/2019];4(2):[aprox. 8 p.]. Disponible en: http://ibbj.org/article-1-183-fa.pdf

13.Galdirs TM, Kappler M, Reich W, Eckert AW. Current aspects of salivary gland tumors - a systematic review of the literature. GMS Interdiscip Plast Reconstr Surg DGPW. [Internet]. 2019 [citado 29/10/2019];8:[aprox. 8 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734194/. https://dx.doi.org/10.3205/iprs000138

14.Sardar MA, Ganvir SM, Hazarey VK. A demographic study of salivary gland tumors. SRM J Res Dent Sci [Internet]. 2018 [citado 29/10/2019];9(2):[aprox. 7 p.]. Disponible en: http://www.srmjrds.in/article.asp?issn=0976-433X;year=2018;volume=9;issue=2;spage=67;epage=73;aulast=Sardar

15.Maahs GS, Oppermann P, Maahs LG, Machado Filho G, Ronchi AD. Parotid gland tumors: a retrospective study of 154 patients. Braz J Otorhinolaryngol [Internet]. 2015 May-Jun [citado 29/10/2019];81(3):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25934418/. https://doi.org/10.1016/j.bjorl.2015.03.007

16.Avila RE, Samar ME, Ferraris RV, Ferraris L, Olmedo LA. Adenoma de células basales: presentación de cinco casos de un raro tumor de glándulas salivales. ORAL [Internet]. 2019 [citado 12/09/2019];20(62):[aprox. 6 p.]. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=88602

17.Jimenez Vidal N. Tumores malignos de glándulas salivales mayores en la comunidad de Madrid. Epidemiología descriptiva y análisis de supervivencia [tesis doctoral]. Madrid: Universidad Complutense de Madrid; 2018 [citado 29/10/2019]. Disponible en: https://eprints.ucm.es/49707/1/T40445.pdf

18.Singh ID, Galagali JR, Kumar S, Kumari A, Gupta AK. A Case of Primary Aggressive Non Hodgkin’s Lymphoma of Parotid Gland. J Otolaryngol-ENT Research [Internet]. 2015 [citado 29/10/2019];3(5):[aprox. 4 p.]. Disponible en: https://medcraveonline.com/JOENTR/a-case-of-primary-aggressive-non-hodgkinrsquos-lymphoma-of-parotid-gland.html. https://doi.org/10.15406/joentr.2015.03.00079

19.Gupta D, Gahlot GPS, Rana V, Jagani R, Swarup D. Primary aggressive non-Hodgkin lymphoma of the parotid gland in a young individual: A case report. International Journal of Case Reports and Images [Internet]. 2014 [citado 29/10/2019];5(5):[aprox. 5 p.]. Disponible en: http://www.ijcasereportsandimages.com/archive/2014/005-2014-ijcri/CR-10385-05-2014-gupta/ijcri-1038505201485-gupta-full-text.php

20.Torabinia N, Khalesi S. Clinicopathological study of 229 cases of salivary gland tumors in Isfahan population. Dent Res J (Isfahan) [Internet]. 2014 Sep-Oct [citado 29/10/2019];11(5):[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241608/

21.Kızıl Y, Aydil U, Ekinci O, Dilci A, Köybaşıoğlu A, Düzlü M, et al. Salivary Gland Tumors in Turkey: Demographic Features and Histopathological Distribution of 510 Patients. Indian J Otolaryngol Head Neck Surg [Internet]. 2013 Jul [citado 29/10/2019];65(Suppl 1):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718936/. https://doi.org/10.1007/s12070-012-0594-6

22.Thielker J, Grosheva M, Ihrler S, Wittig A, Guntinas-Lichius O. Contemporary Management of Benign and Malignant Parotid Tumors. Front Surg [Internet]. 2018 [citado 29/10/2019];5:[aprox. 17 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958460/. https://dx.doi.org/10.3389/fsurg.2018.00039

23.Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw [Internet]. 2020 Jul [citado 08/01/2021];18(7):[aprox. 27 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32634781/. https://doi.org/10.6004/jnccn.2020.0031

24.Shigeishi H, Ohta K, Okui G, Seino S, Hashikata M, Yamamoto K, et al. Clinicopathological analysis of salivary gland carcinomas and literature review. Mol Clin Oncol [Internet]. 2015 Jan [citado 29/10/2019];3(1):[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251114/. https://dx.doi.org/10.3892/mco.2014.441

25.Amorín Ocampo M. Factores clínicos y patológicos asociados a la presencia de metástasis cervical en las neoplasias maligna de parótida y su implicancia quirúrgica en el Departamento de Cabeza y Cuello del Instituto Nacional de Enfermedades Neoplásicas entre los años 2005 a 2015 [tesis doctoral]. Lima: Universidad Peruana Cayetano Heredia; 2019 [citado 29/10/2019]. Disponible en: http://repositorio.upch.edu.pe/handle/upch/6646?show=full&locale-attribute=en

26.Venkatesh S, Srinivas T, Hariprasad S. Parotid gland tumors: 2-year prospective clinicopathological study. Ann Maxillofac Surg [Internet]. 2019 [citado 29/10/2019];9(1):[aprox. 7 p.]. Disponible en: http://www.amsjournal.com/article.asp?issn=2231-0746;year=2019;volume=9;issue=1;spage=103;epage=109;aulast=Venkatesh

Downloads

Published

2021-04-01

How to Cite

1.
Jiménez Rodríguez Y, Coca Granado RM, Delis Fernández RE, Artiles Martínez D, Durán Morales D. Salivary gland tumors. Five years of experience. Acta Méd Centro [Internet]. 2021 Apr. 1 [cited 2025 Jul. 2];15(2):229-3. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1198

Issue

Vol. 15 No. 2 (2021): April-June

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).